Literature DB >> 31387004

Strategy for improved therapeutic efficiency of curcumin in the treatment of gastric cancer.

Milan Jakubek1, Zdeněk Kejík2, Robert Kaplánek3, Róbert Hromádka4, Viera Šandriková5, David Sýkora6, Veronika Antonyová2, Marian Urban7, Petr Dytrych8, Ivan Mikula9, Pavel Martásek10, Vladimír Král11.   

Abstract

Gastric cancer is a common oncological disease. Although enormous efforts have been expended, possible therapeutic modalities are still limited. For this reason, new therapeutic approaches and agents are highly requested and intensively developed. One strategy is the application of natural agents, such as curcumin, with proven anticancer effects and low toxicity for patients. Therefore, this review discusses the potential application of curcumin in the therapy of gastric cancer and its potential incorporation in therapeutic regimens. Because one of the largest impediments for widespread curcumin application is its limited bioavailability (caused mainly by its very low water solubility), studied strategies (drug delivery systems and curcumin derivatization) aimed to solve this obstacle are discussed in more detail.
Copyright © 2019 The Authors. Published by Elsevier Masson SAS.. All rights reserved.

Entities:  

Keywords:  Combination therapy; Curcumin; Curcumin derivatives; Drug delivery system; Gastric cancer

Year:  2019        PMID: 31387004     DOI: 10.1016/j.biopha.2019.109278

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  8 in total

1.  Combination effect of curcumin with docetaxel on the PI3K/AKT/mTOR pathway to induce autophagy and apoptosis in esophageal squamous cell carcinoma.

Authors:  Lian Deng; Xiaoran Wu; Xiongjie Zhu; Zhongjian Yu; Zhile Liu; Jinting Wang; Yanfang Zheng
Journal:  Am J Transl Res       Date:  2021-01-15       Impact factor: 4.060

2.  MiR-28-5p mediates the anti-proliferative and pro-apoptotic effects of curcumin on human diffuse large B-cell lymphoma cells.

Authors:  Tian Kang; Wei-Li Sun; Xiao-Fei Lu; Xin-Liang Wang; Lian Jiang
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

3.  LincROR Mediates the Suppressive Effects of Curcumin on Hepatocellular Carcinoma Through Inactivating Wnt/β-Catenin Signaling.

Authors:  Jiang Shao; Chuan-Jian Shi; Yun Li; Feng-Wei Zhang; Fei-Fei Pan; Wei-Ming Fu; Jin-Fang Zhang
Journal:  Front Pharmacol       Date:  2020-07-02       Impact factor: 5.810

Review 4.  Curcumin's Nanomedicine Formulations for Therapeutic Application in Neurological Diseases.

Authors:  Bahare Salehi; Daniela Calina; Anca Oana Docea; Niranjan Koirala; Sushant Aryal; Domenico Lombardo; Luigi Pasqua; Yasaman Taheri; Carla Marina Salgado Castillo; Miquel Martorell; Natália Martins; Marcello Iriti; Hafiz Ansar Rasul Suleria; Javad Sharifi-Rad
Journal:  J Clin Med       Date:  2020-02-05       Impact factor: 4.241

5.  Essential Oil from Pinus Koraiensis Pinecones Inhibits Gastric Cancer Cells via the HIPPO/YAP Signaling Pathway.

Authors:  Yandong Zhang; Chao Xin; Junqiang Qiu; Zhenyu Wang
Journal:  Molecules       Date:  2019-10-25       Impact factor: 4.411

6.  Improving the Stability and Curcumin Retention Rate of Curcumin-Loaded Filled Hydrogel Prepared Using 4αGTase-Treated Rice Starch.

Authors:  Jihyun Kang; Ye-Hyun Kim; Soo-Jin Choi; Shin-Joung Rho; Yong-Ro Kim
Journal:  Foods       Date:  2021-01-13

Review 7.  Curcumin against gastrointestinal cancer: A review of the pharmacological mechanisms underlying its antitumor activity.

Authors:  Yuanyuan Fan; Xiqin Zhang; Yuxin Tong; Suning Chen; Jingjing Liang
Journal:  Front Pharmacol       Date:  2022-09-02       Impact factor: 5.988

8.  Lycorine hydrochloride inhibits cell proliferation and induces apoptosis through promoting FBXW7-MCL1 axis in gastric cancer.

Authors:  Chongyang Li; Chaowei Deng; Guangzhao Pan; Xue Wang; Kui Zhang; Zhen Dong; Gaichao Zhao; Mengqin Tan; Xiaosong Hu; Shaomin Shi; Juan Du; Haoyan Ji; Xiaowen Wang; Liqun Yang; Hongjuan Cui
Journal:  J Exp Clin Cancer Res       Date:  2020-10-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.